期刊文献+

促红细胞生成素用于脑外伤病人的安全性及护理

下载PDF
导出
摘要 重症脑外伤(TBI)的发生率有增无减,每年因此而引起残疾或死亡者亦在增加,给家庭和社会带来巨大的经济负担。由创伤事件导致神经功能障碍、脑水肿、炎症、细胞凋亡、缺血是治疗面对的重要问题。脑水肿、脑血流量的变化可能增加代谢需要,使得氧供给和消耗之间的平衡被打破,并可引起继发性脑损害。目前对脑外伤的处理原则主要是预防继发性脑损害,最大限度改善患者的神经生存质量。
作者 张燕
出处 《中国实用神经疾病杂志》 2013年第10期89-90,共2页 Chinese Journal of Practical Nervous Diseases
  • 相关文献

参考文献12

  • 1徐潇漪,谌贻璞.新型红细胞生成刺激剂的现状与展望[J].中国血液净化,2010,9(9):467-470. 被引量:5
  • 2Locatelli F, Nissenson AR,Barrett BJ,et al. Clinical practiceguidelines for anemia in chronic kidney disease: problems andsolutions. A position statement from Kidney Disease: Impro-ving Global Outcomes (KDIGO) [J] . Kidney Int, 2008, 74:1237-1 240.
  • 3Siddique MS. Fernandes HM, Wooldridge TD,et al. Reversibleischemia around intracerebral hemorrhage: a single-photon e-mission computerized tomography study [JJ. Journal of Neuro-surgery ,2002, 96(4):736-741.
  • 4Finkelstein FO,Story K,Firanek C,et al. Health relatedquality of life and hemoglobin levels in chronic kidney diseasepatients[J]. Clin J Am Soc Nephrol, 2009,4:33 38.
  • 5Ehrenreich H, Hasselblatt Dembowski C,et al. Erythro-poietin therapy for acute stroke is both safe and beneficial[J].Molecular Medicine,2002,8(8) : 495-505.
  • 6胡兴河.科技创新能力:我国的差距与对策[J].科技进步与对策,2001,18(5):20-21. 被引量:10
  • 7彭秀丽.87例颅脑外伤患者急诊护理体会[J].中国实用神经疾病杂志,2011,14(2):39-40. 被引量:30
  • 8吴娟.重症颅脑外伤患者的肠内营养支持护理体会[J].中国医药指南,2009,7(24):132-133. 被引量:3
  • 9GraSvSO G, Passalacqua M,Sfacteria A, et al. Does admin-istra-tion of recombinant human erythropoietin attenuate the in-crease of S-100 protein observed in cerebrospinal fluid after ex-perimental subarachnoid hemorrhage[J]. Journal of Neurosur-gery ,2002,96(3):565-579.
  • 10Cerami A,Brines ML,Ghezzi P,et al. Effects of epoetinalfa onthe central nervous system[J]. Seminars in Oncology, 2001,28(2): 66-70.

二级参考文献57

  • 1武晔,王岩.急性颅脑损伤急诊护理体会[J].中国社区医师(医学专业),2005,7(10):85-86. 被引量:5
  • 2范军.无情的较量[M].民主与建设出版社,1991..
  • 3何亚平.知识经济:挑战与机遇[M].杭州:浙江人民出版社,1999..
  • 4世界银行.1998/99年发展报告:知识与发展[M].北京:中国财经出版社,1999..
  • 5贾建芬.重型颅脑损伤患者急诊护理体会[J].现代医药卫生,2007,23(15):2331-2332. 被引量:12
  • 6Locatelli F, Nissenson AR, Barrett BJ, et al. Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)[J]. Kidney lnt, 2008.74:1237- 1240.
  • 7Finkelstein FO, Story K, Firanek C, et al. Healthrelated quality of life and hemoglobin levels in chronic kidney disease patients[J]. Clin J Am Soc Nephrol, 2009,4:33 38.
  • 8Ayus JC, Go AS, Valderrabano F, et al. Effects of erythro poietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL[J]. Kidney Int, 2005,68:788-795.
  • 9Go AS, Yang J, Ackerson LM, et al. Hemoglobin level chronic kidney disease, and the risks of death and hospi talization in adults with chronic heart failure: the Ane mia in Chronic Heart Failure: Outcomes and Resource Utili zation (ANCHOR) Study[J]. Circulation, 2006, 113:2713-2723.
  • 10Schiller B, Doss S, E DEC, et al. Costs of managing anemia with erythropoiesis stimulating agents during hemodialysis: a time and motion study[J], Hemodial Int, 2008,12:441- 449.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部